Light- and Melanin Nanoparticle-Induced Cytotoxicity in Metastatic Cancer Cells

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Melanin nanoparticles (mNPs) are generally considered biocompatible.
• Cellular uptake mechanisms, particularly phagocytosis, influence nanoparticle behavior.
• Cancer cell lines like VM-M3, A375, and HeLa exhibit significant nanoparticle ingestion.

Purpose of the Study:

• To investigate the cytotoxic effects of melanin nanoparticles (mNPs) on cancer cells under varying conditions.
• To explore the role of glucose coating in mNP cellular uptake and therapeutic efficacy.
• To assess the susceptibility of mNP-accumulating cancer cells to laser-induced damage.

Main Methods:

• Development of highly monodispersed, uncoated, and glucose-coated melanin nanoparticles (mNPs).
• Utilizing metastatic VM-M3, A375, and HeLa cancer cell lines known for high phagocytic activity.
• Exposing cells to mNPs under varying glucose concentrations and visible light irradiation.

Main Results:

• Metastatic cancer cells demonstrated significant ingestion of mNPs, enhanced by glucose coating.
• High mNP accumulation led to cell death, with glucose coating potentially slowing this process.
• Cells loaded with mNPs were highly susceptible to laser illumination, while non-ingesting cells remained unaffected.
• Non-metastatic VM-NM1 cells did not ingest mNPs and were resistant to laser treatment.

Conclusions:

• Melanin nanoparticles exhibit context-dependent cytotoxicity, particularly in combination with visible light.
• Glucose-coated mNPs can be effectively ingested by metastatic cancer cells, leading to light-sensitized cell death.
• This research offers a potential therapeutic strategy for targeting metastatic cancer stages through nanoparticle-mediated phototoxicity.